Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report-Reference-Cited by-同舟云学术

Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report

Published:2017-11-24 Issue:5 Volume:57 Page:705-708
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Naqash Abdul Rafeh¹^ORCID,Yang Li V.¹,Sanderlin Edward J.¹,Atwell Druid C.¹,Walker Paul R.²

Affiliation:

1. Division of Hematology/Oncology, East Carolina University, Greenville, NC, USA;

2. Thoracic Oncology, East Carolina University, Greenville, NC, USA

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1406668

Reference20 articles.

1. Immune-based Therapies for Non-small Cell Lung Cancer

3. IL-6 as a keystone cytokine in health and disease

4. Inflammation and Cancer: IL-6 and STAT3 Complete the Link

5. C-reactive protein: a critical update

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors;Academic Radiology;2024-09

2. Neoadjuvant Immunotherapy as a risk factor for hashimoto’s disease;Endocrinology & Metabolism International Journal;2024-07-19

3. Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients;BMC Cancer;2024-02-26

4. Pulmonary toxicity of immune checkpoint immunotherapy;Journal of Clinical Investigation;2024-01-16

5. Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effects;Chinese Medical Journal Pulmonary and Critical Care Medicine;2023-12